Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release
about
The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivoApelin signaling antagonizes Ang II effects in mouse models of atherosclerosisThe Apelin-APJ System in the Evolution of Heart FailureApelin-APJ signaling: a potential therapeutic target for pulmonary arterial hypertensionThe hepatic apelin system: a new therapeutic target for liver diseaseCellular localization of apelin and its receptor in the anterior pituitary: evidence for a direct stimulatory action of apelin on ACTH releaseIn vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failureThe Role of the Apelin/APJ System in the Regulation of Liver DiseaseRegulation of the Apelinergic System and Its Potential in Cardiovascular Disease: Peptides and Small Molecules as Tools for Discovery.Role of the Vasopressin/Apelin Balance and Potential Use of Metabolically Stable Apelin Analogs in Water Metabolism Disorders.Association of genetic variants in the apelin-APJ system and ACE2 with blood pressure responses to potassium supplementation: the GenSalt studyBiased signaling favoring gi over β-arrestin promoted by an apelin fragment lacking the C-terminal phenylalaninePressor effect of apelin-13 in the rostral ventrolateral medulla: role of NAD(P)H oxidase-derived superoxideEffect of volume expansion with hypertonic- and isotonic saline and isotonic glucose on sodium and water transport in the principal cells in the kidneySmall expression tags enhance bacterial expression of the first three transmembrane segments of the apelin receptor.Mechanisms involved in dual vasopressin/apelin neuron dysfunction during aging.Galanin and the orexin 2 receptor as possible regulators of enkephalin in the paraventricular nucleus of the hypothalamus: relation to dietary fat.Apelin and energy metabolism.Apelin attenuates UVB-induced edema and inflammation by promoting vessel functionMultiple signalling modalities mediated by dendritic exocytosis of oxytocin and vasopressin.Quantitative functional analysis of protein complexes on surfaces.Clinical Implications of the Serum Apelin Level on Portal Hypertension and Prognosis of Liver CirrhosisSpatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis.Reciprocal regulation of plasma apelin and vasopressin by osmotic stimuliEffect of Aerobic Exercise on Serum Concentration of Apelin, TNFα and Insulin in Obese Women.The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR.The effects of apelin on the electrical activity of hypothalamic magnocellular vasopressin and oxytocin neurons and somatodendritic Peptide release.Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ.The role of apelin in cardiovascular function and heart failure.Abnormal fluid homeostasis in apelin receptor knockout micePhysiological regulation of magnocellular neurosecretory cell activity: integration of intrinsic, local and afferent mechanisms.Endogenous regulation of cardiovascular function by apelin-APJ.Effect of Spironolactone on Plasma Apelin-12 Levels in Patients with Chronic Systolic Heart Failure[Pyr1]Apelin-13(1-12) Is a Biologically Active ACE2 Metabolite of the Endogenous Cardiovascular Peptide [Pyr1]Apelin-13.Fetal and maternal hemodynamics in pregnancy: new insights in the cardiovascular adaptation to uncomplicated pregnancy, twin-to-twin transfusion syndrome and congenital diaphragmatic hernia.The apelinergic system: a promising therapeutic target.Novel neurohormonal insights with therapeutic potential in chronic heart failure.Apelin, diabetes, and obesity.Nanobiology and physiology of growth hormone secretion.Update on apelin peptides as putative targets for cardiovascular drug discovery.
P2860
Q24643958-C14CB6C5-BB9E-40A5-97ED-B933A3118CB6Q24657323-02A990F7-34E6-4C5C-9B41-312898A65BE3Q26777306-2D105080-9323-43F2-B82B-48CD02D6118EQ27010531-9F476B21-DA0E-4ADD-9BD6-3617C5D4963FQ28295197-75D7DDDF-179A-43E2-A42D-2D4AE88C32FCQ28565744-EBB49BF5-A953-46F7-A61E-B384E0510145Q30484162-216498FE-201D-4B17-9D6C-267E12F51563Q33593335-9B2A38FE-4FE6-47B9-A3E1-F07506934595Q33703037-F0041B70-DF73-4026-80EB-51A5146B55C2Q33742305-858AD2B1-9216-4730-AEE6-87024B9E7BFDQ33932245-82642AE1-772E-47F9-815B-198C5D9232B7Q34107370-5C8FB1B2-8869-4E89-9F2B-A96D17B666D1Q34552113-BB0A73BA-A8D8-4032-A0D8-C3E9504983A0Q34997788-3743F31F-6F30-420A-A44E-42F465137828Q35054352-6CAB3A9E-71CD-4377-AF72-4CB07B34020DQ35088157-22E67640-56E2-4DDE-AD2D-0D4CE14D2495Q35210233-555D4463-7EAA-4026-B68C-B9FA15AC88E4Q35352250-FB68C60B-E812-4EC2-9D55-C62D82D44901Q35679447-D71DAE7F-C982-4D9F-B12F-EFD791BFF334Q35683610-77671F3F-A41B-465F-A9AA-190E9C3C220BQ35990983-11050F65-CFF8-4329-92CD-5D8E9FE5E4EBQ36412910-D9965DF4-A5AF-4B11-AAF2-A9012B8520E1Q36456603-F46AED87-A052-4565-968B-A317C588A235Q36662125-42F73F84-2B94-4CD4-9AF8-F70468E36722Q36821917-E183584B-4A63-40A4-A1C3-0257A1AD71B1Q36973488-7B6273E8-486D-4211-ACF9-0A0067AF5A9BQ37161749-13841DEF-FEB7-4B7C-897F-BA3D277768EBQ37194593-B61C1D65-5278-485D-AA5D-E10B2E95C5E8Q37201175-E8515192-113D-47C0-9064-C7E15A95AC16Q37312820-1B926D68-452A-4AA2-878D-E8A081CBB7E3Q37367369-5DEC6C37-6EBF-47D4-BEF0-255ADEBC3F87Q37430874-AFA226A3-1BA7-4115-B76F-1AE262314037Q37448653-5460DEB8-D696-4B7D-9339-79504809C1AFQ37670483-85EECF56-DB8E-499D-BC8C-87D7902BDB17Q37709914-F3B39A38-A0E8-48DE-860C-F4A2A7C0819CQ37720708-73FA02F8-1BF5-426E-897E-9B95F600FE1DQ37749836-89FEC582-5275-4F1F-B9AC-678CB84BAB7CQ37897155-97EF8AA6-60E6-4EA5-AF82-D2993B13D038Q37982020-7E0C41D4-19CB-4D65-A14D-AC9E6FC90DB0Q38014484-FBA52E47-45A6-4EBC-AE7B-0227D5D45C44
P2860
Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release
description
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 2004
@ast
im Juli 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2004/07/13)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/07/13)
@nl
наукова стаття, опублікована в липні 2004
@uk
name
Apelin, a potent diuretic neur ...... tivity and vasopressin release
@ast
Apelin, a potent diuretic neur ...... tivity and vasopressin release
@en
Apelin, a potent diuretic neur ...... tivity and vasopressin release
@nl
type
label
Apelin, a potent diuretic neur ...... tivity and vasopressin release
@ast
Apelin, a potent diuretic neur ...... tivity and vasopressin release
@en
Apelin, a potent diuretic neur ...... tivity and vasopressin release
@nl
prefLabel
Apelin, a potent diuretic neur ...... tivity and vasopressin release
@ast
Apelin, a potent diuretic neur ...... tivity and vasopressin release
@en
Apelin, a potent diuretic neur ...... tivity and vasopressin release
@nl
P2093
P2860
P3181
P356
P1476
Apelin, a potent diuretic neur ...... tivity and vasopressin release
@en
P2093
Annabelle Reaux-Le Goazigo
Catherine Llorens-Cortes
Claude Kordon
Cynthia Dujardin
Darren Roesch
Françoise Moos
Hubert Vaudry
Nadia De Mota
Nicolas Chartrel
Said El Messari
P2860
P304
10464–10469
P3181
P356
10.1073/PNAS.0403518101
P407
P577
2004-07-13T00:00:00Z